Need a specific person's email?
Browse Triumvira Immunologics, Inc.'s employee directory (about 21 employees) and reveal verified emails free.
Triumvira Immunologics, Inc.'s most common email format is FLast@triumvira.com (ex. JDoe@triumvira.com), used for 95% of triumvira.com addresses. Triumvira Immunologics, Inc. uses 3 email patterns.
| Format | Example | Share of triumvira.com |
|---|---|---|
| FLast@triumvira.comMost common | JDoe@triumvira.com | |
| First_Last@triumvira.com | John_Doe@triumvira.com | |
| FMiddleLast@triumvira.com | JMichaelDoe@triumvira.com |
Browse Triumvira Immunologics, Inc.'s employee directory (about 21 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States11-50 Employees
Triumvira Immunologics, Inc. is a biotechnology company based in San Francisco, California, focused on developing T cell–based therapies for solid tumors. It pursues a proprietary approach to harness the natural biology of T cells, with the aim of achieving improved safety and efficacy relative to existing treatments such as CAR-T and engineered TCR therapies. The company traces its origins to 2015, when it was founded through licensing from McMaster University and Bloom Burton & Co. Triumvira's target market includes clinicians and pharmaceutical development partners seeking novel autologous and allogeneic T cell therapeutics to treat solid tumors. A notable development is a clinical trial collaboration and supply agreement with Merck announced in 2023. In 2025 the company continued to present updated clinical data at industry conferences, reflecting ongoing activity in its programs.
Most common format
FLast@triumvira.com
Example: JDoe@triumvira.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.